Disc Medicine Inc (IRON)
33.91
-0.72
(-2.08%)
USD |
NASDAQ |
May 31, 16:00
33.94
+0.03
(+0.09%)
After-Hours: 20:00
Disc Medicine Total Assets (Quarterly): 354.18M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 354.18M |
| December 31, 2023 | 368.00M |
| September 30, 2023 | 376.50M |
| June 30, 2023 | 384.17M |
| March 31, 2023 | 243.78M |
| December 31, 2022 | 200.20M |
| September 30, 2022 | 106.03M |
| Date | Value |
|---|---|
| June 30, 2022 | 113.33M |
| March 31, 2022 | 124.28M |
| December 31, 2021 | 92.41M |
| September 30, 2021 | 155.54M |
| June 30, 2021 | 172.42M |
| March 31, 2021 | 189.38M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
92.41M
Minimum
Dec 2021
384.17M
Maximum
Jun 2023
221.56M
Average
189.38M
Median
Mar 2021
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals Inc | 855.10M |
| Alnylam Pharmaceuticals Inc | 3.824B |
| Marinus Pharmaceuticals Inc | 137.35M |
| Rocket Pharmaceuticals Inc | 499.44M |
| Regenxbio Inc | 629.22M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 16.11M |
| Shareholders Equity (Quarterly) | 338.07M |